Ami Organics Limited (AMIORG) - Total Liabilities

Latest as of March 2025: Rs2.29 Billion INR ≈ $24.79 Million USD

Based on the latest financial reports, Ami Organics Limited (AMIORG) has total liabilities worth Rs2.29 Billion INR (≈ $24.79 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Ami Organics Limited - Total Liabilities Trend (2014–2025)

This chart illustrates how Ami Organics Limited's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Ami Organics Limited's assets to evaluate the company's liquid asset resilience ratio.

Ami Organics Limited Competitors by Total Liabilities

The table below lists competitors of Ami Organics Limited ranked by their total liabilities.

Company Country Total Liabilities
Eastcompeace Technology Co Ltd
SHE:002017
China CN¥1.19 Billion
Ramsay Generale De Sante
PA:GDS
France €5.41 Billion
Xiangtan Electrochemical Scientific Co Ltd
SHE:002125
China CN¥1.87 Billion
Kunshan Huguang Auto Harness Co Ltd
SHG:605333
China CN¥4.82 Billion
Guangzhou Newlife New Material Co. Ltd. A
SHE:301323
China CN¥145.09 Million
Shanghai Tongji Science&Technology Industrial Co Ltd
SHG:600846
China CN¥8.38 Billion
thyssenkrupp nucera AG & Co. KGaA
XETRA:NCH2
Germany €384.00 Million
HHC Changzhou Corp.
SHE:301061
China CN¥1.03 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Ami Organics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Ami Organics Limited (AMIORG) total assets.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.91 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ami Organics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ami Organics Limited (2014–2025)

The table below shows the annual total liabilities of Ami Organics Limited from 2014 to 2025.

Year Total Liabilities Change
2025-03-31 Rs2.29 Billion
≈ $24.79 Million
-44.53%
2024-03-31 Rs4.13 Billion
≈ $44.68 Million
+138.84%
2023-03-31 Rs1.73 Billion
≈ $18.71 Million
+26.62%
2022-03-31 Rs1.37 Billion
≈ $14.77 Million
-44.54%
2021-03-31 Rs2.46 Billion
≈ $26.64 Million
+105.15%
2020-03-31 Rs1.20 Billion
≈ $12.99 Million
-8.29%
2019-03-31 Rs1.31 Billion
≈ $14.16 Million
+33.76%
2018-03-31 Rs978.86 Million
≈ $10.59 Million
+39.68%
2017-03-31 Rs700.79 Million
≈ $7.58 Million
+7.87%
2016-03-31 Rs649.65 Million
≈ $7.03 Million
+46.40%
2015-03-31 Rs443.74 Million
≈ $4.80 Million
+58.84%
2014-03-31 Rs279.37 Million
≈ $3.02 Million
--

About Ami Organics Limited

NSE:AMIORG India Specialty Chemicals
Market Cap
$1.18 Billion
Rs108.67 Billion INR
Market Cap Rank
#8239 Global
#413 in India
Share Price
Rs1327.40
Change (1 day)
+0.00%
52-Week Range
Rs1327.40 - Rs1327.40
All Time High
Rs2626.70
About

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as wel… Read more